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In Europe, each year, more than four milion patients acquire a healthcare-associated
infection (HAI) and almost 40 thousand die as a direct consequence of it. Regardless
of many stategies to prevent and control HAIs, they remain an important cause of
morbidity and mortality worldwide with a significant economic impact: a recent estimate
places it at the ten billion dollars/year. The control of HAIs requires a prompt and
efficient identification of the etiological agent and a rapid communication with the
clinician. The Microbiology Laboratory has a significant role in the prevention and
control of these infections and is a key element of any Infection Control Program.
The work of the Microbiology Laboratory covers microbial isolation and identification,
determination of antimicrobial susceptibility patterns, epidemiological surveillance and
outbreak detection, education, and report of quality assured results. In this paper we
address the role and importance of the Microbiology Laboratory in the prevention and
control of HAI and in Antibiotic Stewardship Programs and how it can be leveraged when
combined with the use of information systems. Additionally, we critically review some
challenges that the Microbiology Laboratory has to deal with, including the selection of
analytic methods and the proper use of communication channels with other healthcare
services.
Keywords: microbiology, healthcare-associated infections, antibiotics, antibiotic stewardship, information
systems, prevention, control, communication
INTRODUTION
Healthcare-associated infections (HAIs) are a significant cause of morbidity and mortality
leading to 37,000 deaths/year in Europe1 and 75,000 deaths in USA in 2011 (Magill et al.,
2014). The HAIs economic impact is also significant: about 9.8 billion dollars/year/USA for
the five major infections (Zimlichman et al., 2013). Antibiotic resistance is one of the major
1http://ecdc.europa.eu/en/healthtopics/Healthcare-associated_infections
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problems associated with HAIs (Cosgrove, 2006; Neidell et al.,
2012): the Centers for Disease Prevention and Control (CDC)
estimates that over two million people/year acquire antibiotic
resistant infections, and 23,000 die as a result of it (CDC, 2013).
In Europe, 25,000 people/year die with drug-resistant infections
(ECDC, 2009).
Prevention through education is the most used strategy
for HAIs control: the benefits from prevention can be
as high as 5.5 billion dollars (Zimlichman et al., 2013).
Reinforcing hand washing, staff education, environmental
cleaning practices, Antibiotic Stewardship Programs (ASPs) and
improved communication systems are measures implemented
worldwide to control HAIs. However, to efficiently control HAIs,
clinicians need to act quickly, which implies gathering all relevant
information about the infection as soon as possible. That is why
the Microbiology Laboratory is so important in HAIs prevention
and control since it is in the front line for the early identification
of infection, characterization of antibiotic resistance patterns and
recognition of outbreaks (Diekema and Saubolle, 2011; Davey
et al., 2013).
Traditionally, the tasks of the Microbiology Laboratory are to
isolate, identify and determine antibiotic susceptibility patterns of
pathogens (Wilson and Spencer, 1999). However, its scope covers
other areas that are critical for Infection Control Programs as
well as to ASPs, which should ideally include a member of the
Microbiology Laboratory staff (Kolmos, 1999; Benbachir, 2008;
CDC, 2014). The success of these kind of programs depends
largely on the active involvement of the Microbiology Laboratory
in activities beyond the regular microbiology exams, namely
in results report, surveillance, communication, and other daily
routine tasks of Infection Control Teams (Kalenic´ and Budimir,
2009).
In this paper, we describe the multiple chores of the
Microbiology Laboratory highlighting its importance in HAIs
prevention and control, and in ASPs, especially when combined
with properly designed information systems. We also review
some of the problems that the Microbiology Laboratory has to
deal with when assisting Infection Control Teams, including the
selection of the most appropriate analytic methods to provide fast
and accurate results.
TASKS OF THE MICROBIOLOGY
LABORATORY
Microbial Isolation and Identification
The Microbiology Laboratory main task is to isolate and identify
the infection etiological agent (Benbachir, 2008), using the
most appropriate, rapid and accurate diagnostic method. To
ensure this, the Microbiology Laboratory needs to keep up-to-
date materials, culture media, reagents, equipment, identification
methods and trained personnel (CDC, 2003). The staff needs
continuous on-the-job training in microbiological techniques
and to be updated on the internationally endorsed methods
for isolation and characterization of pathogens (Pfaller and
Herwaldt, 1997; Benbachir, 2008). In addition, external and
internal quality control and assurance programs must be
implemented to guarantee the quality of the results (Benbachir,
2008).
Determination of Antimicrobial
Susceptibility Patterns
The Microbiology Laboratory should provide frequently updated
information on antimicrobial resistance patterns, essential
to design appropriate hospital prescription guidelines, help
clinicians to choose the most appropriate empiric therapy and
to create a culture of patient safety (Pfaller and Herwaldt,
1997; Benbachir, 2008). This data can be analyzed in different
perspectives, including infectious agent, specimen, ward, clinical
specialty, antibiotics prescribed, or anatomic site of infection,
among others (Pfaller and Herwaldt, 1997; Benbachir, 2008).
The availability of periodic reports on local antimicrobial
resistance patterns is also relevant in ASPs, since it can be used
to evaluate trends of antimicrobial resistance rates, to educate
clinicians on optimal antimicrobial use and to assess the impact
of prevention measures (Diekema and Saubolle, 2011).
Report of the Results
The laboratory work is completed only when it is effectively
reported (Newton and Novak-Weekley, 2011). All laboratory
results (preliminary and final) should be reported as soon as
possible to clinicians and Infection Control Teams (Kalenic´ and
Budimir, 2009). Daily reports on significant microbiology results
and periodic reports with frequency of isolated pathogens and
prevalence of resistant microorganisms provide clinicians and
Infection Control Teams with accurate and timely information,
essential to follow trends of hospital infections and control urgent
situations (Pfaller and Herwaldt, 1997; Benbachir, 2008).
These reports can be delivered through meetings, phone,
information systems alerts, paper, or e-mail. However, making
results accessible through an information system is an advantage
by ensuring that all results are available in an organized,
easily accessible, and timely manner, and also permits links
to other surveillance data systems (Cantón, 2005). Information
systems that incorporate information about the patient, disease,
infectious agent and antimicrobial susceptibility are fundamental
because they promote timely exchange of information between
healthcare workers (Schreckenberger and Binnicker, 2011). For
instance, ARTEMIS (Teodoro et al., 2012) and HAITool2 (Pinto
et al., 2016) are good examples of this kind of systems.
They analyze heterogeneous data sources and can be used to
build antimicrobial resistance surveillance networks participating
in the management and prevention of antibiotic resistant
HAIs, and by doing so, optimizing human and economic
resources2 (Teodoro et al., 2012). Some of these systems
alert the clinician (or the pharmacist) when laboratory results
reveal that the antibiotic(s) in use may not be optimal or
when de-escalation treatment is indicated (Schreckenberger and
Binnicker, 2011; Pinto et al., 2016). The “processed information”
generated by these systems are very useful for surveillance
purposes and in supporting and leveraging ASPs (Davey et al.,
2013).
2http://haitool.ihmt.unl.pt/
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Surveillance and Outbreak Detection
Surveillance enables the identification of infected patients, the
origin of HAIs and to understand their paths of spread. Since
most of this data comes from microbiological isolates and other
laboratory identification tests (Emori and Gaynes, 1993; Peterson
and Brossette, 2002), the Microbiology Laboratory has a central
role not only on the surveillance and early detection of outbreaks
but also on monitoring and reporting unusual laboratory results
(e.g., clusters of pathogens, emergence of multidrug-resistant
organisms, isolation of unusual pathogens).
To detect outbreaks early enough to mitigate their impact
on morbidity and mortality is one of the major challenges
of an efficient surveillance program (Diekema and Saubolle,
2011). The Microbiology Laboratory, in association with the
Infections Control Team, is the first to detect an outbreak because
unusual clusters of pathogens or resistance patterns are easily
noticed (Arias, 2010). During an outbreak, these two entities
have to work side by side to: (i) provide information on the
epidemiology of the etiologic agent; (ii) identify and store the
isolates involved for further testing; (iii) define/select appropriate
selective isolation media and drug susceptibility testing (if
needed/when applicable); (iv) perform the appropriate tests for
strain typing (or provide its dispatch to a reference laboratory);
(v) and perform supplemental microbiological surveillance of
patients, personnel, or environmental sources of infection (Emori
and Gaynes, 1993; Pfaller and Herwaldt, 1997; Arias, 2010).
As described above, the use of surveillance systems can
enhance surveillance programs by aggregating all the information
related with patient, disease, infectious agent and antimicrobial
susceptibility, making easier outbreaks detection.
Education
To maximize the efficacy of Infection Control programs,
the Microbiology Laboratory should provide training and
information on basic microbiology and biosafety for healthcare
workers in areas such as: specimen collection, handling and
transport, epidemiologically important pathogens vs. normal
flora, colonization vs. infection, interpretation of microbiological
results (Kalenic´ and Budimir, 2009). Written guidelines about
sampling, handling and transport should be available in every
ward, which can also include details on the tests available for
proper isolation, identification, and typing of microorganisms
(Grosek, 1999).
ANTIBIOTIC STEWARDSHIP PROGRAMS
Antibiotic Stewardship Programss should be included in all HAIs
prevention and control programs and are essential for gathering
information about epidemiological and molecular markers of
resistance, and changes in resistance patterns. They not only
contribute to the optimization of antimicrobial therapy, by
ensuring proper use (indication, dose, route of administration,
and duration) and minimizing side effects, but also promote
education on it (Davey et al., 2013). The adoption of these
programs leads to a reduction in the prevalence of antimicrobial
resistance and costs (Malani et al., 2012). These programs have
been implemented throughout the world and there are guidelines
and recommendations for their use in the USA (CDC, 2014;
Fridkin et al., 2014) and Europe (Pina, 2002; Department of
Health Advisory Committee on Antimicrobial Resistance and
Healthcare Associated Infection, 2011; Lower et al., 2013; Simões
et al., 2015).
Also here, computerized surveillance and decision support
systems are a good support for ASPs, since have proven to
be effective in the prescription errors reduction, medical care
improvement and compliance with recommendations (Evans
et al., 1998; Pestotnik, 2005).
A schematic representation of the network of interactions in
ASPs is shown in Figure 1. The laboratory imparts an important
function in ASPs, generating most of the relevant information
needed to characterize the biology of the pathogen (and the
hosts), namely its identification, antimicrobial susceptibility
patterns and epidemiological connections. Therefore, it is
recommended that all ASPs include a microbiologist (CDC,
2014). A good example of the role of Microbiology Laboratory in
ASPs is described by MacKenzie et al. (2007) who demonstrated
that hospitals with routine reports on antimicrobial susceptibility
patterns for restricted antibiotics had lower usage (and misusage)
of these antibiotics.
ISSUES ON THE LABORATORY EFFICACY
Sample’s Quality and Access to Clinical
Data
The quality of the laboratory diagnosis is closely related with
the quality of the collected samples (Benbachir, 2008). Samples
should be taken on the correct time and from appropriate
sites, using proper techniques and in amounts that makes
possible to perform all the tests necessary for the isolation and
identification (and other testing) of the pathogen (Department
of Health Advisory Committee on Antimicrobial Resistance and
Healthcare Associated Infection, 2011). Samples that are not
properly collected and transported may lead to false results
(Benbachir, 2008).
Relevant epidemiological and clinical information data are
also important for accurate laboratory diagnosis. Every request
for exam should include: name of the patient, name of the
clinician in charge, location of the patient, date and time
of specimen collection, short anamnesis including suspected
diagnosis and underlying patient conditions and comorbidities
(Benbachir, 2008; Kalenic´ and Budimir, 2009). The access to
this pre-analytic data facilitates significantly the guidance toward
pathogen detection and identification. These kind of information
should be easily accessed throughout an information system.
Isolation in Culture or Molecular
Identification Methods, Which One to
Choose?
The use of laboratory culture methods for isolation of pathogens
followed by identification procedures (biochemical, molecular,
serologic, or other) has been the gold standard in Medical
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FIGURE 1 | Network of interactions in an Antibiotic Stewardship Program.
Microbiology and continues to play a vital role in the overall
management of infectious diseases. As an example, blood culture
is still mandatory for isolation and identification of blood
pathogens and guiding therapy (Book et al., 2013). However,
isolation in culture has limitations, namely being time consuming
(Singh et al., 2006). Results provided 48 to 72 h after the onset
of the infection often have limited impact on therapy (Tenover,
2010) and the ability of the laboratory to provide results in a
timely manner is essential.
Conversely, the major benefit of direct molecular methods
is related to time saving. Using Polymerase Chain Reaction
(PCR) based methods, results can be obtained within 6 to
8 h, reducing greatly the time-to-result and implementation
of appropriate therapy (Book et al., 2013). Molecular methods
have been described as a powerful tool against the spread of
microorganisms in hospital environment, in particular during
outbreaks (Singh et al., 2006), and many have been used to
rapidly identify microorganisms (e.g., multiplex PCR, Real-
time PCR, MALDI-TOF MS), to find resistance patterns (e.g.,
PCR/hybridization screening of resistance determinants) and to
estimate epidemiological links between bacteria (e.g., pulsed-field
gel electrophoresis, multi-locus sequence typing), enabling rapid
and appropriate therapeutic responses (Cantón, 2005; Simões
et al., 2011; Sabat et al., 2013; Patel, 2015; Srinivasan et al., 2015).
More recently whole-genome sequencing (WGS) promises to
transform Infection Control. WGS provides almost all the genetic
information needed for epidemiological studies (Köser et al.,
2012) and has been widely used to identify and control outbreaks
of antibiotic resistant HAIs (Reuter et al., 2013; Price et al.,
2013). WGS can be used to quickly identify pathogenic agents
from specimens and unravel many genomic single nucleotide
polymorphisms and markers for drug resistance, allowing the
implementation of immediate and appropriate control measures
(Coll et al., 2014). However, the translation of the large amount
of data generated by WGS to the clinical utility is still under
development (Burke and Korngiebel, 2015).
Molecular methods have been associated with global cost
reduction, due to their high specificity, sensitivity and rapid
turnaround (Cantón, 2005; Tenover, 2010; Currie, 2011).
Combining molecular typing with surveillance programs was
shown to be cost effective and result in significant reduction of
HAIs rates (Hacek et al., 1999). More recently, the integration
of rapid identifications methods with stewardship interventions
has been described as a way to improve time to optimal antibiotic
therapy, decrease length of hospital stay and reduce mortality and
healthcare costs (Huang et al., 2013; Bauer et al., 2014; Perez et al.,
2014).
However, molecular methods do not solve all the problems.
Several authors have described drawbacks associated with
molecular methods: limited number of detectable pathogens,
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possibility of false positives and complex sample preparation
procedures (Laxminarayan et al., 2013). In addition, molecular
methods are more expensive, require specialized equipment, and
training (Morshed et al., 2007) and their value in diagnosis of
some infections has not been fully proven. For instance, in a
recent study testing the accuracy of SeptiFast multi-pathogens
real-time PCR, authors concluded that, despite providing faster
results, this method has limited utility in bloodstream infections,
when compared with conventional blood culture (Warhurst et al.,
2015). Additionally, there are several microorganisms for which
isolation by culture methods is the most effective and recommend
procedure especially when dealing with drug-resistant inducible
geno/phenotypes.
The dispute on isolation in culture followed by identification
versus direct identification from specimen by molecular methods
seems endless and unnecessary since both methods can be used
in concert. Several authors suggested a combination of culture
and molecular methods in order to increase the rate, efficacy
and accuracy of pathogen detection. (Dolinger and Jacobs, 2011;
Brown-Elliott and Wallace, 2012; Huttunen et al., 2013). Table 1
summarizes some pros and cons of both strategies.
Antimicrobial Resistance Surveillance
With the emergence and spread of antimicrobial resistant
pathogens, antimicrobial resistance surveillance is becoming an
important task of the Microbiology Laboratory. Antimicrobial
resistance surveillance is an ongoing (and organized) data
collection that after being analyzed and reported provides useful
information for empirical antimicrobial therapy (Cornaglia et al.,
2004).
Nevertheless, a good surveillance program is time consuming
and involve dedicated human resources. In addition there are
several challenges on data collection, management, analysis,
interpretation and reporting. For instance, promoting the use of
new and low-cost technologies to improve laboratory work and
to prioritize which bacteria are most important to track are issues
that should be addressed (Solomon and Ijaz, 2015). Regarding
interpretation, uniformization is needed: currently, different
guidelines and breakpoints for evaluation of antimicrobials
susceptibility patterns values are adopted in the United States of
America and within several European countries (Vernet et al.,
2014). Finally, the results should be presented in formats easily
understandable by the clinicians (Grundmann et al., 2011).
Information systems are a good way to keep-it working
smoothly (Lapão, 2007). As stated above, surveillance
information systems ensure that antimicrobial resistance
related data are available and organized, making easy to
report it retrospectively. In addition, surveillance information
systems allow better antibiotic resistance management and
help to provide evidence based results that can be used for the
development of control policies (Evans et al., 1998; Pestotnik,
2005).
Communication
Effective communication is critical for the Microbiology
Laboratory procedures. Nevertheless, it can also be one of
its major issues. Effective communication is the base of a
healthy collaboration between laboratory, healthcare workers
and Infection Control Teams (Kalenic´ and Budimir, 2009). The
dialog between healthcare workers and laboratory staff must be
easy and effective (Peterson et al., 2001). The existence of a
dedicated laboratory staff element (privileged interlocutor) and
the participation of microbiologists in regular clinician’s meetings
is recommended. Efficient communication between clinicians
and microbiologists about the presumptive diagnosis, accelerates
the diagnosis and avoids problems with inappropriate specimens
(Baron et al., 2013).
In order to facilitate communication, it is recommended that
the director of the Microbiology Laboratory be a clinician or
a laboratory scientist with expertise in infectious diseases and
TABLE 1 | Comparison of culture and molecular identification methods.
Culture methods Molecular methods
Specificity Moderate High
Sensitivity Low High
Antimicrobial susceptibility Isolates can be tested for susceptibility to relevant
antibiotics
Allows the detection of some resistance markers without
isolation/culturing
Amount needed to detected pathogens High Low
Time to obtain results Long (especially for slow-growers organisms) Short
Cost Low High (variable)
Detection of non-viable bacteria (patient in
antibiotic treatment)
No Yes
Equipment Requires non-specialized equipment Requires specialized equipment
Biosafety Potential biosafety concerns Minimizes biosafety concerns
Feasibility Requires basic training
No specialized workflow required
Requires advanced training
Assays may not be commercially available
Others Allows visual inspection of colony morphology
Allows biochemical characterization of phenotype
Limited potential for false positives and/or false
negatives
Allows high resolution analysis
Potential false positives (by cross-reaction with closely related
species or contaminated amplicons)
Potential false negatives (by inhibition components or target
mutations)
Adapted from (Dolinger and Jacobs, 2011).
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microbiology (Thomson et al., 2010) since their background on
disease pathologic process facilitates the discussion of clinical
cases. Additionally, information systems have an important
role in communication within the hospitals by facilitating
the exchange of clinical and microbiological relevant data
between clinicians and laboratories (Lapão, 2007). However, it
is important that information systems are defined and designed
together with the healthcare workers in order to really improve
communication, data quality, be useful on decision-making and
be easy to use (Pinto et al., 2016).
Another reality that can affect the communication is the
location of the Microbiology Laboratory. There are an increasing
number of off-site laboratories providing services to hospitals
and in the cases of in-house laboratories, they usually are
in the basement or in an annex outside the hospital main
building. It has been described that off-site laboratories delay and
decrease communication, could jeopardizes infection diagnosis
and treatment and weaken infection prevention and antibiotic
stewardship infrastructures (Peterson et al., 2001; Dancer et al.,
2015).
CONCLUSION
The Microbiology Laboratory plays a key role in HAIs prevention
and control. From ensuring appropriate specimen collection and
transport, to the wise selection of isolation and identification
methods and finally on the antibiotic therapy guidance plus
effective report and communication of the results, the laboratory
covers all important aspects of infection control process. The
microbiologist is a fundamental and enriching member of
ASPs and Infection Control Teams. The new identifications
methods (including WGS) combined with the emergence of
innovative and centralized information systems that integrate
the microbiology results with clinical data will revolutionize
HAIs prevention and control strategies, help decision-making
and resolve some of the difficulties felt by the microbiologists.
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